1 Min Read
March 9 (Reuters) - Progenics Pharmaceuticals Inc
* Progenics Pharmaceuticals announces fourth quarter and full-year 2016 financial results and business update
* Q4 loss per share $0.10 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.